Literature DB >> 22328951

GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population.

Liqing Zhou, Xiaojiao Zhang, Xuechao Chen, Li Liu, Chao Lu, Xiaohu Tang, Juan Shi, Meng Li, Mo Zhou, Zhouwei Zhang, Lingchen Xiao, Ming Yang.   

Abstract

Vitamin D has potent anticancer properties, especially against gastrointestinal cancers. Group-specific component (GC), a key member of vitamin D pathway proteins, could bind to and transport vitamin D to target organs. As a polymorphic protein, two common coding single nucleotide polymorphisms (SNP) [Glu416Asp (rs7041) and Thr420Lys (rs4588)] were identified in its gene. These SNPs have been associated to circulating vitamin D levels and several cancer risks in different populations. However, there is no report on their role in gastrointestinal cancer development among Chinese to date. Therefore, we examined the association between these variants and risk of gastrointestinal cancers in a case-control cohort including 964 patients with four gastrointestinal cancers (hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer) and 1187 controls. Odds ratios and 95% confidence intervals were estimated by logistic regression. We found that GC Thr420Lys polymorphism has significant impact on the risk of developing gastrointestinal cancers, especially colorectal cancer. Additionally, subjects who carrying GC Asp(416)-Lys(420) haplotype, which contains the at-risk 420Lys allele, also showed significantly increased risk to develop gastrointestinal cancers. In conclusion, our study demonstrated that common genetic variants and haplo-types in GC may influence individual susceptibility to gastrointestinal cancers in Chinese population.

Entities:  

Keywords:  Group-specific component; gastrointestinal cancer; single nucleotide polymorphism; susceptibility

Year:  2012        PMID: 22328951      PMCID: PMC3272689     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  34 in total

1.  Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.

Authors:  La Creis R Kidd; Dina N Paltoo; Songping Wang; Weidong Chen; Folasade Akereyeni; William Isaacs; Chiledum Ahaghotu; Rick Kittles
Journal:  Prostate       Date:  2005-08-01       Impact factor: 4.104

2.  Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women.

Authors:  A L Lauridsen; P Vestergaard; A P Hermann; C Brot; L Heickendorff; L Mosekilde; E Nexo
Journal:  Calcif Tissue Int       Date:  2005-05-05       Impact factor: 4.333

3.  Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats.

Authors:  J L Jourdan; J Akhter; P Bowrey; M Pourgholami; D L Morris
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

4.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.

Authors:  Edward Giovannucci; Yan Liu; Eric B Rimm; Bruce W Hollis; Charles S Fuchs; Meir J Stampfer; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

5.  Calcium, vitamin D, and risk of adenoma recurrence (United States).

Authors:  Maria Elena Martínez; James R Marshall; Richard Sampliner; Jody Wilkinson; David S Alberts
Journal:  Cancer Causes Control       Date:  2002-04       Impact factor: 2.506

6.  Do sunlight and vitamin D reduce the likelihood of colon cancer?

Authors:  C F Garland; F C Garland
Journal:  Int J Epidemiol       Date:  1980-09       Impact factor: 7.196

Review 7.  Vitamin D and prevention of breast cancer.

Authors:  JoEllen Welsh
Journal:  Acta Pharmacol Sin       Date:  2007-09       Impact factor: 6.150

Review 8.  1,25-Dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies.

Authors:  M H Pourgholami; D L Morris
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

9.  Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP).

Authors:  J Arnaud; J Constans
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

10.  Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women.

Authors:  Marc Sinotte; Caroline Diorio; Sylvie Bérubé; Michael Pollak; Jacques Brisson
Journal:  Am J Clin Nutr       Date:  2008-12-30       Impact factor: 7.045

View more
  17 in total

Review 1.  Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches.

Authors:  Davide Serrano; Matteo Lazzeroni; Bernardo Bonanni
Journal:  Mol Oncol       Date:  2014-12-20       Impact factor: 6.603

2.  Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk.

Authors:  Xinyu Yang; Dianke Yu; Yanli Ren; Jinyu Wei; Wenting Pan; Changchun Zhou; Liqing Zhou; Yu Liu; Ming Yang
Journal:  Am J Hum Genet       Date:  2016-07-21       Impact factor: 11.025

3.  The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer.

Authors:  Şermin Durak; Arezoo Gheybi; Şeyda Demirkol; Soykan Arıkan; Ş Ümit Zeybek; Filiz Akyüz; İlhan Yaylım; Özlem Küçükhüseyin
Journal:  Mol Biol Rep       Date:  2019-09-23       Impact factor: 2.316

4.  The ALDH7A1 genetic polymorphisms contribute to development of esophageal squamous cell carcinoma.

Authors:  Haiyong Wang; Lei Tong; Jinyu Wei; Wenting Pan; Lichao Li; Yunxia Ge; Liqing Zhou; Qipeng Yuan; Changchun Zhou; Ming Yang
Journal:  Tumour Biol       Date:  2014-09-12

5.  Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival.

Authors:  Jinyu Kong; Fangxiu Xu; Jinli Qu; Yu Wang; Ming Gao; Herbert Yu; Biyun Qian
Journal:  Oncotarget       Date:  2015-02-10

6.  The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study.

Authors:  Rolf Jorde; Henrik Schirmer; Tom Wilsgaard; Ellisiv Bøgeberg Mathiesen; Inger Njølstad; Maja-Lisa Løchen; Ragnar Martin Joakimsen; Guri Grimnes
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

7.  Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.

Authors:  Qiliu Peng; Shi Yang; Xianjun Lao; Ruolin Li; Zhiping Chen; Jian Wang; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Leukocyte telomere length-related rs621559 and rs398652 genetic variants influence risk of HBV-related hepatocellular carcinoma.

Authors:  Wenting Pan; Guangxia Cheng; Huaixin Xing; Juan Shi; Chao Lu; Jinyu Wei; Lichao Li; Changchun Zhou; Qipeng Yuan; Liqing Zhou; Ming Yang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 9.  Common variants of the vitamin D binding protein gene and adverse health outcomes.

Authors:  Suneil Malik; Lei Fu; David James Juras; Mohamed Karmali; Betty Y L Wong; Agnes Gozdzik; David E C Cole
Journal:  Crit Rev Clin Lab Sci       Date:  2013-02-22       Impact factor: 6.250

10.  Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.

Authors:  Xiayu Wu; Jiaoni Cheng; Kaiyun Yang
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.